Grünenthal’s non-opioid pain drug gets breakthrough tag
pharmaphorum
MAY 23, 2023
Grünenthal’s non-opioid pain drug gets breakthrough tag Phil.Taylor Tue, 05/23/2023 - 08:20 Bookmark this
tag opioids 
52 
Judge rules CVS, Walgreens, and Walmart owe $650M in opioids suit
STAT News
AUGUST 17, 2022
CLEVELAND — A federal judge in Cleveland awarded $650 million in damages Wednesday to two Ohio counties that won a landmark lawsuit against national pharmacy chains CVS, Walgreens and Walmart, claiming the way they distributed opioids to customers caused severe harm to communities and created a public nuisance.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pear claims breakthrough tag for alcohol use disorder DTx
pharmaphorum
NOVEMBER 24, 2021
The DTx – also known as Pear-009 – is still in the proof-of-concept trial stage, but draws on the same cognitive behavioural therapy (CBT) deployed in Pear’s commercial-stage products reSET and reSET-O for people living with substance and opioid use disorders. Photo by thom masat on Unsplash.
Grand Rounds June 16, 2023: BeatPain Utah: Partnering With Community Health Centers Within a Socio-Technical Framework (Julie Fritz, PT, PhD, FAPTA; Guilherme Del Fiol, MD, PhD)
Rethinking Clinical Trials
JULY 9, 2023
However, persons in low-income and rural communities have significantly higher odds of receiving a prescription opioid for a new back pain diagnosis. Use of nonpharmacologic pain treatments is lower in rural settings and for persons of Hispanic/Latino ethnicity.
Gene Silencing Porphyria Treatment, Givlaari, Finally Wins Over England’s NICE Amid Stellar Long-Term Data
XTalks
OCTOBER 26, 2021
The treatment came with an initial price tag of $39,000 per vial, which amounts to a total of $575,00 each year. After participating in a clinical trial evaluating the gene silencing treatment, the sisters told BBC that, “the difference is astronomical, we’re not in pain anymore,” and that they don’t have to rely on opioids for pain relief.
A history of Johnson & Johnson
pharmaphorum
FEBRUARY 26, 2021
The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. This is not the only controversy J&J has had to deal with in recent years.
Ep. 005 – Dave Chase Podcast Transcript
Pharma Marketing Network
JUNE 8, 2020
I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.
Let's personalize your content